IMPROVEMENT IN TREATMENT SATISFACTION AMONG PRIMARY IMMUNODEFICIENCY PATIENTS ON AN INVESTIGATIONAL 20 % SUBCUTANEOUS IMMUNOGLOBULIN THERAPY

被引：0
|
作者：
Meckley, Lisa [1 ]
Ito, Diane [1 ]
Hu, Xingdi [1 ]
Yel, Leman [2 ]
机构：
[1] Baxalta US Inc, HEOR, Cambridge, MA USA
[2] Baxalta US Inc, Immunol, Clin Sci, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2016年 / 36卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
4335
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [21] Treatment Satisfaction Upon Switching To Flexibly-dosed Subcutaneous Immunoglobulin G In Primary Immunodeficiency
    Jones, Claire
    Noorani, Sadia
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 2 - 2
  • [22] High-flow 20% subcutaneous immunoglobulin G in patients with primary immunodeficiency disease
    McCrary, Kaley
    Leiding, Jennifer W.
    Duff, Carla
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (03) : 344 - 346
  • [23] Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push
    Shapiro, R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 173 (02): : 365 - 371
  • [24] Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases
    Mach-Tomalska, Monika
    Pituch-Noworolska, Anna
    Bien, Ewa
    Malanowska, Magdalena
    Machura, Edyta
    Pukas-Bochenek, Anna
    Chrobak, Ewelina
    Pac, Malgorzata
    Pietrucha, Barbara
    Drygala, Szymon
    Kamieniak, Marta
    Kasprzak, Jakub
    Heropolitanska-Pliszka, Edyta
    IMMUNOTHERAPY, 2024, 16 (06) : 391 - 403
  • [25] Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy
    Jolles, Stephen
    Cristea, Victor
    Wahn, Volker
    Debre, Marianne
    Longhurst, Hilary
    Zenker, Othmar
    Peter, Hans-Hartmut
    Borte, Michael
    CLINICAL IMMUNOLOGY, 2010, 135 : S86 - S87
  • [26] The effect of subcutaneous immunoglobulin replacement therapy on serum IgG levels in patients with primary immunodeficiency
    Boluk, Selime Ozen
    Akcal, Omer
    Taskirdi, Ilke
    Haci, Idil Akay
    Kaya, Mehmet Sirin
    Celik, Figen Celebi
    Soyoz, Ozgen
    Karkiner, Canan
    Gulez, Nesrin
    Genel, Ferah
    TRENDS IN PEDIATRICS, 2023, 4 (02): : 103 - 108
  • [27] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
    Hirokazu Kanegane
    Kohsuke Imai
    Masafumi Yamada
    Hidetoshi Takada
    Tadashi Ariga
    Martin Bexon
    Mikhail Rojavin
    Wilson Hu
    Midori Kobayashi
    John-Philip Lawo
    Shigeaki Nonoyama
    Toshiro Hara
    Toshio Miyawaki
    Journal of Clinical Immunology, 2014, 34 : 204 - 211
  • [28] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
    Kanegane, Hirokazu
    Imai, Kohsuke
    Yamada, Masafumi
    Takada, Hidetoshi
    Ariga, Tadashi
    Bexon, Martin
    Rojavin, Mikhail
    Hu, Wilson
    Kobayashi, Midori
    Lawo, John-Philip
    Nonoyama, Shigeaki
    Hara, Toshiro
    Miyawaki, Toshio
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (02) : 204 - 211
  • [29] Infusion parameters of 20% subcutaneous immunoglobulin for primary immunodeficiency diseases among patient support program participants
    Meckley, Lisa M.
    Wu, Yanyu
    Tzivelekis, Spiros
    Gandhi, Vivek
    Gladiator, Andre
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : 568 - +
  • [30] Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
    John B. Hagan
    Mary B. Fasano
    Sheldon Spector
    Richard L. Wasserman
    Isaac Melamed
    Mikhail A. Rojavin
    Othmar Zenker
    Jordan S. Orange
    Journal of Clinical Immunology, 2010, 30 : 734 - 745
12345